These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 27137831
1. [The effect of drugs used in treatment of skin disorders on visual system]. Szostakiewicz-Grabek B, Juszkiewicz-Borowiec M, Krasowska D. Pol Merkur Lekarski; 2016 Apr; 40(238):269-72. PubMed ID: 27137831 [Abstract] [Full Text] [Related]
2. Ocular changes induced by drugs commonly used in dermatology. Turno-Kręcicka A, Grzybowski A, Misiuk-Hojło M, Patryn E, Czajor K, Nita M. Clin Dermatol; 2016 Apr; 34(2):129-37. PubMed ID: 26903180 [Abstract] [Full Text] [Related]
3. Ocular side effects of systemic therapy of cutaneous diseases. Sugar J. Int Ophthalmol Clin; 1985 Apr; 25(1):173-83. PubMed ID: 3972487 [No Abstract] [Full Text] [Related]
7. Drugs affecting the eye. Taylor F. Aust Fam Physician; 1985 Aug; 14(8):744-5. PubMed ID: 2864912 [Abstract] [Full Text] [Related]
8. [Skin and eyes]. Kohl E, Hillenkamp J, Landthaler M, Szeimies RM. Ophthalmologe; 2010 Mar; 107(3):281-92; quiz 293. PubMed ID: 20309669 [Abstract] [Full Text] [Related]
9. Photosensitizing drugs and their possible role in enhancing ocular toxicity. Parker Heath memorial lecture. Lerman S. Ophthalmology; 1986 Mar; 93(3):304-18. PubMed ID: 3085038 [Abstract] [Full Text] [Related]
10. The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease. Day A, Abramson AK, Patel M, Warren RB, Menter MA. J Am Acad Dermatol; 2014 May; 70(5):821.e1-19. PubMed ID: 24742849 [Abstract] [Full Text] [Related]
11. Ocular toxicity and hydroxychloroquine: guidelines for screening. Jones SK. Br J Dermatol; 1999 Jan; 140(1):3-7. PubMed ID: 10215761 [Abstract] [Full Text] [Related]
12. Ocular effects of oral retinoids. Lebowitz MA, Berson DS. J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):209-11. PubMed ID: 3045165 [Abstract] [Full Text] [Related]
13. Methotrexate: role of treatment in skin disease. Holliday AC, Moody MN, Berlingeri-Ramos A. Skin Therapy Lett; 2013 Jul; 18(3):4-9. PubMed ID: 23674145 [Abstract] [Full Text] [Related]
16. [Skin and eyes]. Kohl E, Hillenkamp J, Landthaler M, Szeimies RM. Hautarzt; 2009 Jan; 60(1):63-74; quiz 75. PubMed ID: 19130027 [Abstract] [Full Text] [Related]
17. [Ophthalmological monitoring protocol for patients treated with long-term antimalarials or vigabatrin]. Ingster-Moati I, Orssaud C. J Fr Ophtalmol; 2009 Jan; 32(1):83-8. PubMed ID: 19515321 [Abstract] [Full Text] [Related]
18. Antimalarials in dermatology: mechanism of action, indications, and side effects. Rodriguez-Caruncho C, Bielsa Marsol I. Actas Dermosifiliogr; 2014 Apr; 105(3):243-52. PubMed ID: 24656224 [Abstract] [Full Text] [Related]
19. [Drug-induced eye lesions in the aged]. Slezak H. Aktuelle Gerontol; 1983 Sep; 13(5):187-90. PubMed ID: 6139035 [Abstract] [Full Text] [Related]
20. [Adverse effects of some modern drugs on the visual apparatus]. Knobloch R. Cesk Oftalmol; 1971 Nov; 27(6):367-73. PubMed ID: 5138253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]